MX2019009036A - Composicion topica. - Google Patents

Composicion topica.

Info

Publication number
MX2019009036A
MX2019009036A MX2019009036A MX2019009036A MX2019009036A MX 2019009036 A MX2019009036 A MX 2019009036A MX 2019009036 A MX2019009036 A MX 2019009036A MX 2019009036 A MX2019009036 A MX 2019009036A MX 2019009036 A MX2019009036 A MX 2019009036A
Authority
MX
Mexico
Prior art keywords
topical composition
polyaphron dispersion
composition
crisaborole
topical application
Prior art date
Application number
MX2019009036A
Other languages
English (en)
Inventor
Crutchley Nigel
Georgiou Michelle
Original Assignee
Mc2 Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mc2 Therapeutics Ltd filed Critical Mc2 Therapeutics Ltd
Publication of MX2019009036A publication Critical patent/MX2019009036A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una composición para aplicación tópica que comprende una dispersión de poliafrón, en donde la dispersión de poliafrón comprende una fase continua, una fase discontinua y crisaborole.
MX2019009036A 2017-01-31 2018-01-30 Composicion topica. MX2019009036A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1701583.5A GB201701583D0 (en) 2017-01-31 2017-01-31 Topical composition
PCT/GB2018/050263 WO2018142117A1 (en) 2017-01-31 2018-01-30 Topical composition

Publications (1)

Publication Number Publication Date
MX2019009036A true MX2019009036A (es) 2019-09-26

Family

ID=58462739

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019009036A MX2019009036A (es) 2017-01-31 2018-01-30 Composicion topica.

Country Status (13)

Country Link
US (1) US11744799B2 (es)
EP (1) EP3576716B1 (es)
JP (1) JP6975244B2 (es)
KR (1) KR102585047B1 (es)
CN (1) CN110234316A (es)
AU (1) AU2018215386B2 (es)
BR (1) BR112019015435A2 (es)
CA (1) CA3051799A1 (es)
ES (1) ES2952202T3 (es)
GB (1) GB201701583D0 (es)
IL (1) IL268374B2 (es)
MX (1) MX2019009036A (es)
WO (1) WO2018142117A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201701583D0 (en) 2017-01-31 2017-03-15 Drug Delivery Solutions Ltd Topical composition
CA3105417A1 (en) * 2018-07-31 2020-02-06 MC2 Therapeutics Limited A composition comprising a continuous aqueous phase, a discontinuous liquid oil phase and crisaborole

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486333A (en) 1981-04-10 1984-12-04 Felix Sebba Preparation of biliquid foam compositions
FR2710840B1 (fr) 1993-10-04 1995-12-01 Applic Transferts Technolo Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.
US6165479A (en) * 1996-03-08 2000-12-26 Disperse Technologies Limited Dispersions comprising an oil-based biliquid foam and an aqueous gel
GB0317868D0 (en) 2003-07-30 2003-09-03 Disperse Ltd Biliquid foams with a high alcohol content and products formulated therefrom
GB0401101D0 (en) * 2004-01-19 2004-02-18 Disperse Ltd Dispersions
AU2006214247C1 (en) * 2005-02-16 2012-11-08 Anacor Pharmaceuticals, Llc Boron-containing small molecules
RS54108B1 (en) 2006-02-16 2015-12-31 Anacor Pharmaceuticals Inc. SMALL MOLECULES CONTAINING BORON AS AGENTS FOR INFLAMMATION
EP1970047A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with a corticosteroid
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970049A1 (en) 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid
EP1970048A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
JP5745279B2 (ja) * 2008-01-09 2015-07-08 アナコール ファーマシューティカルズ，インコーポレイテッド 抗炎症剤としてのホウ素含有小分子
EP3246034A1 (en) * 2008-03-06 2017-11-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
EP2461871A2 (en) * 2009-08-06 2012-06-13 Peter Thomas Roth Labs, Llc Compositions for promoting a healthy appearance of the skin
WO2014083099A1 (en) * 2012-11-30 2014-06-05 Leo Pharma A/S A method of inhibiting the expression of il-22 in activated t-cells
EP3383363B1 (en) * 2015-11-30 2021-01-06 Anacor Pharmaceuticals, Inc. Topical pharmaceutical formulations for treating inflammatory-related conditions
WO2017102565A1 (en) 2015-12-15 2017-06-22 Rita Dobmeyer Pharmaceutical composition comprising a fulvic acid and at least one boron-containing compound
US11458125B2 (en) 2016-04-04 2022-10-04 MC2 Therapeutics Limited Topical composition comprising tacrolimus
WO2018031655A1 (en) 2016-08-09 2018-02-15 Board Of Regents, The University Of Texas System Stimuli-responsive polymer particles and methods of using thereof
GB201701583D0 (en) 2017-01-31 2017-03-15 Drug Delivery Solutions Ltd Topical composition
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
CA3105417A1 (en) 2018-07-31 2020-02-06 MC2 Therapeutics Limited A composition comprising a continuous aqueous phase, a discontinuous liquid oil phase and crisaborole

Also Published As

Publication number Publication date
WO2018142117A1 (en) 2018-08-09
AU2018215386B2 (en) 2023-08-31
US20220110868A1 (en) 2022-04-14
IL268374A (en) 2019-09-26
ES2952202T3 (es) 2023-10-30
EP3576716C0 (en) 2023-06-21
BR112019015435A2 (pt) 2020-03-24
US11744799B2 (en) 2023-09-05
EP3576716A1 (en) 2019-12-11
JP6975244B2 (ja) 2021-12-01
KR102585047B1 (ko) 2023-10-04
JP2020506925A (ja) 2020-03-05
CA3051799A1 (en) 2018-08-09
AU2018215386A1 (en) 2019-07-25
IL268374B2 (en) 2023-10-01
KR20190109511A (ko) 2019-09-25
CN110234316A (zh) 2019-09-13
IL268374B1 (en) 2023-06-01
GB201701583D0 (en) 2017-03-15
EP3576716B1 (en) 2023-06-21

Similar Documents

Publication Publication Date Title
EP3526192B8 (en) Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
WO2019020602A3 (en) LUMINOPHORE AND COMPOSITION
AU2018258581A8 (en) RAF-degrading conjugate compounds
MX2018001045A (es) Compuestos de piridina utiles para combatir hongos fitopatogenos.
MX2019011759A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando el mismo.
MX2022000053A (es) Moduladores de interaccion de sestrina-gator2 y sus usos.
EP3407720A4 (en) MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS AND METHODS RELATING THERETO
EP3407718A4 (en) MOLECULES WITH PESTICIDE FUNCTION AND INTERMEDIATE PRODUCTS, COMPOSITIONS AND METHODS THEREFOR
EP3408262A4 (en) MOLECULES WITH PESTICIDE FUNCTION AND INTERMEDIATE PRODUCTS, COMPOSITIONS AND METHODS THEREFOR
MX2019011758A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma.
EP3722395A4 (en) Anti-friction compound and anti-friction compound with the anti-friction compound
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
EP3408263A4 (en) MOLECULES HAVING PESTICIDAL UTILITY AND INTERMEDIATE PRODUCTS, COMPOSITIONS AND RELATED METHODS
EP3659581A4 (en) TOPICAL COMPOSITION
EP3654982A4 (en) 1,8-NAPHTHYRIDINONE COMPOUNDS AND THEIR USES
EP3655043A4 (en) TOPICAL COMPOSITIONS AND THEIR USES
EP3344339A4 (en) MOLECULES WITH PESTICIDE FUNCTION AND INTERMEDIATE PRODUCTS, COMPOSITIONS AND METHODS THEREFOR
MX2019010950A (es) Composicion de fotosensibilizador que contiene fenalen-1-ona, compuesto de fenalen-1-ona, asi como su uso.
EP3344599A4 (en) MOLECULES HAVING UTILITY AS A PESTICIDE, AND INTERMEDIATES THEREOF, COMPOSITIONS AND METHODS
EP3407716A4 (en) MOLECULES WITH PESTICIDE FUNCTION AND INTERMEDIATE PRODUCTS, COMPOSITIONS AND METHODS THEREFOR
EP3347341B8 (en) Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
EP3344600A4 (en) MOLECULES HAVING UTILITY AS A PESTICIDE, AND INTERMEDIATES THEREOF, COMPOSITIONS AND METHODS
MX2021001258A (es) Composicion topica.
EP3407717A4 (en) MOLECULES WITH PESTICIDE FUNCTION AND INTERMEDIATE PRODUCTS, COMPOSITIONS AND METHODS THEREFOR
MX2019009036A (es) Composicion topica.